Showing results (41-50 of 141) with videos related to
Sort By:
Pageof 15
Cancer Research|November 4, 2010
A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironmentAngela D Pardee, Dustin McCurry, Sean Alber, et al.SLAS Discovery : Advancing Life Sciences R & D|November 19, 2020
Unbiased High-Throughput Drug Combination Pilot Screening Identifies Synergistic Drug Combinations Effective against Patient-Derived and Drug-Resistant Melanoma Cell LinesDavid A Close, John M Kirkwood, Ronald J Fecek, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligandGanwei Lu, Bratislav M Janjic, Jelena Janjic, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2010
Intralesional delivery of dendritic cells engineered to express T-bet promotes protective type 1 immunity and the normalization of the tumor microenvironmentYanyan Qu, Lu Chen, Angela D Pardee, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathwayBratislav M Janjic, Ganwei Lu, Alexei Pimenov, et al.Cancer Research|May 4, 2012
Combination therapy with HSP90 inhibitor 17-DMAG reconditions the tumor microenvironment to improve recruitment of therapeutic T cellsAparna Rao, Jennifer L Taylor, Nina Chi-Sabins, et al.Cancer Research|April 19, 2006
Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10Fumihiko Nishimura, Jill E Dusak, Junichi Eguchi, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
IL-4-transfected tumor cell vaccines activate tumor-infiltrating dendritic cells and promote type-1 immunityJunichi Eguchi, Naruo Kuwashima, Manabu Hatano, et al.Pigment Cell Research|May 20, 2003
Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin?Anna Wankowicz-Kalinska, Caroline Le Poole, Rene van den Wijngaard, et al.International Journal of Cancer|July 19, 2002
Progenipoietin-generated dendritic cells exhibit anti-tumor efficacy in a therapeutic murine tumor modelPia Björck, Wen-Rong Lie, Susan L Woulfe, et al.Pageof 15